This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lynch, S. G Articles by Denney, D. R Search for Related Content PubMed PubMed Citation Articles by Lynch, S. G Articles by Denney, D. R Social Bookmarking                         What's this?

The association between cognitive impairment and physical disability in multiple sclerosis

Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USA

Brett A Parmenter

Department of Psychology, University of Kansas, Lawrence, KS 66045, USA

Douglas R Denney

Department of Psychology, University of Kansas, Lawrence, KS 66045, USA, denney{at}ku.edu

Background: The association between cognitive impairment and physical disability was examined in a larger, more representative sample of patients with multiple sclerosis (MS) than in previous studies. Method: Two hundred and fifty-three patients attending an MS clinic were assessed with respect to physical disability using the Expanded Disability Status Scale and cognitive impairment using a battery of neuropsychological tests. Results: Physical disability correlated with duration of disease; cognitive impairment did not. Virtually all measures derived from the cognitive battery were significantly correlated with physical disability. Three measures of speeded information processing and one involving delayed recall of verbal material were unique predictors of disability status. The relationship between cognitive impairment and physical disability was equivalent for patients with shorter (<3 years) versus longer (>10 years) disease duration. Cognitive impairment correlated with the rate of disability progression as reflected by the progression index. Conclusion: Cognitive impairment is more closely associated with physical disability than most previous studies indicate. This relationship appears to be stable throughout the duration of MS, although this conclusion is qualified by the cross-sectional design of the study. Further attention should be paid to cognitive impairment as a possible predictor of the rate of patients’ physical decline.

Key Words: cognition • cognitive impairment • disability • multiple sclerosis • neuropsychology

Multiple Sclerosis, Vol. 11, No. 4, 469-476 (2005)
DOI: 10.1191/1352458505ms1182oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. Patti, M. Amato, S. Bastianello, L. Caniatti, E. Di Monte, P. Ferrazza, B. Goretti, P. Gallo, V. Brescia Morra, S. Lo Fermo, et al. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing--remitting multiple sclerosis Multiple Sclerosis, January 1, 2010; 16(1): 68 - 77. [Abstract] [PDF]

				F Patti, M. Amato, M Trojano, S Bastianello, M. Tola, B Goretti, L Caniatti, E Di Monte, P Ferrazza, V Brescia Morra, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study Multiple Sclerosis, July 1, 2009; 15(7): 779 - 788. [Abstract] [PDF]

				F. Patti, M. Pia Amato, S. Bastianello, L. Caniatti, E. Di Monte, F. Lijoi, B. Goretti, S. Messina, O. Picconi, M. R. Tola, et al. Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing--remitting multiple sclerosis: 2-year results from the COGIMUS study Therapeutic Advances in Neurological Disorders, March 1, 2009; 2(2): 67 - 77. [Abstract] [PDF]

				F Patti Cognitive impairment in multiple sclerosis Multiple Sclerosis, January 1, 2009; 15(1): 2 - 8. [Abstract] [PDF]

				B A Parmenter, D R Denney, S G Lynch, L S Middleton, and L M Harlan Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms Multiple Sclerosis, January 1, 2007; 13(1): 25 - 32. [Abstract] [PDF]